IART — INTEGRA LIFESCIENCES HOLDINGS CORP
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 917520 ·
Last close
$15.19
Market Cap
$1.18B
52W High
$15.45
52W Low
$8.70
ADV30
1,087,466
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 391,918,000 | 216,982,000 | 11,470,000 | -4,617,000 | 3,577,726,000 | 236,809,000 | 2,535,320,000 |
| Dec 2025 | 434,925,000 | 220,865,000 | 23,040,000 | -1,704,000 | 3,602,001,000 | 235,048,000 | 2,558,538,000 |
| Sep 2025 | 402,062,000 | 206,991,000 | 11,761,000 | -5,404,000 | 3,646,452,000 | 232,186,000 | 2,608,878,000 |
| Jun 2025 | 415,605,000 | 209,332,000 | -1,309,000 | -484,073,000 | 3,667,905,000 | 217,914,000 | 2,629,244,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$71,444,000
Investing CF
$-86,991,000
Financing CF
$1,255,000
CapEx
$-81,566,000
Dividends Paid
—
Buybacks
$-2,471,000
EPS Diluted TTM
$-6.46
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$418,824,000
Inventory
$495,035,000
Receivables
$264,413,000
ST Investments
$28,693,000
EBIT TTM
$-445,970,000
Pretax Income TTM
$-535,875,000
Interest Exp TTM
$89,905,000
Analysts
6
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,644,509,952
EBITDA
$308,296,992
Free Cash Flow
$69,289,752
Enterprise Value
$2,950,110,208
Total Cash
$265,502,000
Total Debt
$2,040,878,976
Shares Out
77,796,903
Trailing EPS
$-6.47
Book Value
$13.39
ROE
-38.6%
ROA
2.5%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,635,245,000 | 17,995,000 | -516,474,000 | 3,602,001,000 | 2,558,538,000 | — | 50,384,000 |
| Dec 2024 | 1,610,527,000 | 28,411,000 | -6,944,000 | 4,037,424,000 | 2,492,144,000 | — | 129,382,000 |
| Dec 2023 | 1,541,573,000 | 111,526,000 | 67,741,000 | 3,781,988,000 | 2,194,104,000 | — | 139,955,000 |
| Dec 2022 | 1,557,666,000 | 238,920,000 | 180,550,000 | 3,889,758,000 | 2,085,355,000 | — | 264,469,000 |
TTM Snapshot
Revenues TTM
$1,535,307,000
NetIncome TTM
$101,946,000
OpCashFlow TTM
$0
Assets (Latest)
$4,037,424,000
Forward EPS
$2.61
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| IRMD | IRADIMED CORP | $1.19B | $92.94 | — |
| BLFS | BIOLIFE SOLUTIONS INC | $1.17B | $24.03 | — |
| AVNS | AVANOS MEDICAL, INC. | $1.16B | $24.75 | — |
| INSP | Inspire Medical Systems, Inc. | $1.21B | $41.99 | — |
| ATEC | Alphatec Holdings, Inc. | $1.24B | $8.06 | — |
News headlines (Yahoo Finance, 1h cache)
3 Inflated Stocks That Concern Us
2026-05-26 10:43 · Yahoo
3 Stocks Under $50 with Open Questions
2026-05-22 21:16 · Yahoo
Integra LifeSciences (IART) is a Top-Ranked Value Stock: Should You Buy?
2026-05-22 13:40 · Yahoo
A Look At Integra LifeSciences Holdings (IART) Valuation After Recent Share Price Momentum
2026-05-21 00:29 · Yahoo
IART or MASI: Which Is the Better Value Stock Right Now?
2026-05-18 15:40 · Yahoo
Why Integra LifeSciences (IART) is a Top Momentum Stock for the Long-Term
2026-05-18 13:50 · Yahoo
[Latest] Global Orthopedic Soft Tissue Repair Market Size/Share Worth USD 15.38 Billion by 2035 at a 9.6 CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation
2026-05-18 12:30 · Yahoo
Integra LifeSciences Says Transformation Is Working as SurgiMend Relaunch Nears
2026-05-17 22:02 · Yahoo
The Top 5 Analyst Questions From Integra LifeSciences’s Q1 Earnings Call
2026-05-15 05:08 · Yahoo
Integra LifeSciences (IART) Is Up 6.4% After Essig Returns As CEO With Reaffirmed 2026 Guidance
2026-05-14 17:17 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.